These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5788155

  • 1. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR, Erickson EH.
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Irreversible enzyme inhibitors. CLXV. Proteolytic enzymes. XV. Inhibition of guinea pig complement by derivatives of m-phenoxypropoxybenzamidine.
    Baker BR, Cory M.
    J Med Chem; 1969 Nov; 12(6):1053-6. PubMed ID: 5389147
    [No Abstract] [Full Text] [Related]

  • 5. Complement inhibition by amidines and guanidines--in vivo and in vitro results.
    Otterness IG, Torchia AJ, Doshan HD.
    Biochem Pharmacol; 1978 Nov; 27(14):1873-8. PubMed ID: 708469
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of acrosin by benzamidines.
    Stürzebecher J.
    Acta Biol Med Ger; 1981 Nov; 40(10-11):1519-22. PubMed ID: 7044006
    [Abstract] [Full Text] [Related]

  • 11. Irreversible enzyme inhibitors. 180. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine and phenoxyacetamide.
    Baker BR, Cory M.
    J Med Chem; 1971 Feb; 14(2):119-25. PubMed ID: 5544395
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH.
    J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J, Markwardt F.
    Biochem Pharmacol; 1977 Feb 15; 26(4):325-9. PubMed ID: 849323
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
    Stürzebecher J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Feb 15; 109(1):83-8. PubMed ID: 6177613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
    Hoffmann A, Markwardt F.
    Pharmazie; 1989 Feb 15; 44(2):141-4. PubMed ID: 2748697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.